Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA).

MLA

Nassar-Sheikh Rashid, A., et al. “Therapeutic Drug Monitoring of Anti-TNF Drugs: An Overview of Applicability in Daily Clinical Practice in the Era of Treatment with Biologics in Juvenile Idiopathic Arthritis (JIA).” Pediatric Rheumatology Online Journal, vol. 19, no. 1, Apr. 2021, p. 59. EBSCOhost, https://doi.org/10.1186/s12969-021-00545-x.

APA

Nassar-Sheikh Rashid, A., Schonenberg-Meinema, D., Bergkamp, S. C., Bakhlakh, S., de Vries, A., Rispens, T., Kuijpers, T. W., Wolbink, G., & van den Berg, J. M. (2021). Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA). Pediatric Rheumatology Online Journal, 19(1), 59. https://doi.org/10.1186/s12969-021-00545-x

Chicago

Nassar-Sheikh Rashid, A, D Schonenberg-Meinema, S C Bergkamp, S Bakhlakh, A de Vries, T Rispens, T W Kuijpers, G Wolbink, and J M van den Berg. 2021. “Therapeutic Drug Monitoring of Anti-TNF Drugs: An Overview of Applicability in Daily Clinical Practice in the Era of Treatment with Biologics in Juvenile Idiopathic Arthritis (JIA).” Pediatric Rheumatology Online Journal 19 (1): 59. doi:10.1186/s12969-021-00545-x.